BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TTL, 2410003M22Rik, 150465, ENSG00000114999, MGC46235, Q8NG68
26 results:

  • 1. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
    Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
    Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVAttl Pro 3 Study.
    Martín-Salvago MD; Sancho M; López-García MÁ; Cano Jiménez A; Pérez-Luque A; Alfaro L; Vieites B
    Breast Cancer Res Treat; 2023 Jul; 200(2):203-215. PubMed ID: 37219637
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in breast cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Total Tumor Load to assist in the decision for additional axillary surgery in the positive sentinel node breast cancer patients.
    Sousa N; Peleteiro B; Fougo JL
    Surg Oncol; 2022 Dec; 45():101882. PubMed ID: 36395579
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intraoperative sentinel node biopsy, is it worth the wait?
    García Chiloeches A; González Barranquero A; Juéz Sáez LD; Corral Moreno S; Rivas Fidalgo S; Pastor Peinado P; Cabañas Montero LJ; Fernández Cebrián JM
    Cir Esp (Engl Ed); 2023 May; 101(5):325-332. PubMed ID: 36152966
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Can clinicopathological factors improve the prediction of metastasis to nonsentinel lymph nodes in patients with breast cancer?
    García-Mejido JA; Sánchez-Sevilla M; González-Martínez J; Fernández-Palacín A; Sainz-Bueno JA
    Cir Cir; 2022; 90(4):473-480. PubMed ID: 35944438
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intraoperative Molecular Analysis of Total Tumor Load in Sentinel Lymph Node: A Predictor of Axillary Status in Early breast cancer.
    Laohawiriyakamol S; Mahattanobon S; Puttawibul P
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):349-354. PubMed ID: 35092404
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study.
    Kenny R; Wong G; Gould L; Odofin O; Bowyer R; Sotheran W
    Ann R Coll Surg Engl; 2022 Mar; 104(3):216-220. PubMed ID: 34928727
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVAttl study.
    Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
    Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Axillary staging based on molecular analysis: Results of the B-CLOSER-II study.
    Sansano I; Vieites B; Sancho de Salas M; García C; Amendoeira I; Bernet L; Pérez-García JM; Espinosa-Bravo M; Rubio IT; Ramón Y Cajal S; Peg V
    Pathol Res Pract; 2020 Nov; 216(11):153197. PubMed ID: 32919301
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. One-step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement.
    Cuffolo G; Gahir-Atwal HK; Smith B
    Breast J; 2020 Oct; 26(10):2002-2005. PubMed ID: 32677735
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients.
    Piñero-Madrona A; Ripoll-Orts F; Sánchez-Méndez JI; Chaves-Benito A; Gómez-de la Bárcena MR; Calatrava-Fons A; Menjón-Beltrán S; Peg-Cámara V
    Breast Cancer Res Treat; 2020 Jun; 181(2):339-345. PubMed ID: 32253684
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sentinel node total tumour load as a predictive factor for non-sentinel node status in early breast cancer patients - The porttle study.
    Fougo JL; Amendoeira I; Brito MJ; Correia AP; Gonçalves A; Honavar M; Machado A; Magalhães A; Marta S; Nogueira M; Peleteiro B; Pontes P
    Surg Oncol; 2020 Mar; 32():108-114. PubMed ID: 31987574
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
    Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
    Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in breast cancer Patients with Sentinel Node Metastasis.
    Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
    Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.
    Peg V; Sansano I; Vieites B; Bernet L; Cano R; Córdoba A; Sancho M; Martín MD; Vilardell F; Cazorla A; Espinosa-Bravo M; Pérez-García JM; Cortés J; Rubio IT; Ramón Y Cajal S
    Breast; 2017 Jun; 33():8-13. PubMed ID: 28254641
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Antimetabolite ttl-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.
    DuHadaway J; Prendergast GC
    Oncotarget; 2016 Feb; 7(7):7372-80. PubMed ID: 26840263
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.